Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07924605
PHASE2

PSMA PET/MRI for Predicting and Detecting Prostate Cancer

Sponsor: University of Wisconsin, Madison

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to see if a drug called 18F-DCFPyL can help find prostate cancer or prostate cancer that has spread to other parts of the body. The main question it aims to answer is: * Can 18F-DCFPyL predict response to therapy; and, * Does 18F-DCFPyL improve detection of early signs of cancer. Participants will undergo PET/MRI scans.

Official title: PSMA PET/MRI to Predict Tumor Response to Neoadjuvant Systemic Therapy in Men With High-Risk Prostate Cancer, and Detection of Cancer in Men With Very Low to Intermediate-Risk Prostate Cancer

Key Details

Gender

MALE

Age Range

18 Years - 85 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2026-12

Completion Date

2031-12

Last Updated

2026-11-09

Healthy Volunteers

No

Interventions

DEVICE

PSMA PET

Participants will complete 75 minutes of scans.

DEVICE

MRI

Participants will complete 75 minutes of scans.

DRUG

18F-DCFPyL

18F-DCFPyL will be injected through an IV in the arm.

Locations (1)

University of Wisconsin - Madison

Madison, Wisconsin, United States